J. M. Amici, M. Battistella, and M. Beylot-barry, Defining and recognising locally 302 advanced basal cell carcinoma, Eur J Dermatol, vol.25, pp.586-94, 2015.

G. Zoccali, R. Pajand, and P. Papa, Giant basal cell carcinoma of the skin: literature 304 review and personal experience, J Eur Acad Dermatol Venereol, vol.26, pp.942-52, 2012.

A. A. Jacobsen, A. S. Aldahan, and O. B. Hughes, Hedgehog Pathway Inhibitor Therapy 306 for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and 307 Pooled Analysis of Interventional Studies, JAMA Dermatol, vol.152, pp.816-840, 2016.

S. L. Shingler, J. Garside, and K. Samanta, Utilities for advanced basal cell carcinoma

, Med Econ, vol.16, pp.777-83, 2013.

A. W. Haves, P. R. Schaffer, and J. A. Carucci, The impact of inoperable advanced basal cell 311 carcinoma: the economic, physical, and psychological burden of the disease, J Drugs 312 Dermatol, vol.12, pp.151-153, 2013.

B. Antoszewski, A. Kasielska, and M. Fija?kowska, Face Skin Neoplasms -Reasons for

, Delayed Treatment. Polish Journal of Surgery, vol.83, 2011.

S. Blackford, D. Roberts, M. S. Salek, and A. Finlay, Basal cell carcinomas cause little 316 handicap, Qual Life Res, vol.5, pp.191-195, 1996.

H. Husein-elahmed, M. Gutierrez-salmeron, R. Naranjo-sintes, A. , and J. ,

, Factors related to delay in the diagnosis of basal cell carcinoma, J Cutan Med Surg, 2013.

W. J. Sahl, S. N. Snow, and N. S. Levine, Report of two cases and 321 review of the literature, J Am Acad Dermatol, vol.30, pp.856-865, 1994.

M. Alam, L. H. Goldberg, and S. Silapunt, , vol.36, pp.738-782

J. K. Robinson, J. S. Altman, and A. W. Rademaker, Socioeconomic status and attitudes of 51

L. E. Wiznia, K. M. Shanley, and D. G. Federman, Advanced, neglected basal cell carcinoma

, South Med J, vol.107, pp.242-247, 2014.

S. Yamamoto, M. Johno, and K. Kayashima, Giant basal cell carcinoma associated 376 with systemic amyloidosis, J Dermatol, vol.23, pp.329-363, 1996.

S. Sinha, M. J. Yip, and S. Gill, A giant fungating metastatic basal cell carcinoma of the

, Reconstr Aesthet Surg, vol.66, pp.1015-1023, 2013.

J. Wang, H. Cao, L. Liu, and Y. , Mushroom-like giant basal cell carcinoma on

M. D. Laudenschlager, K. J. Donelan, and D. W. Lynch, Opting for Christian Science vs

, S D Med, vol.64, issue.325, p.329, 2011.

T. Suyama, Y. Teramoto, and A. Yamamoto, Case of giant basal cell carcinoma 386 around the base of the penis in an elderly patient, J Dermatol, vol.41, pp.439-481, 2014.

E. Varga, I. Korom, and Z. Raskó, Neglected Basal Cell Carcinomas in the 21st

. Century, Journal of Skin Cancer, vol.2011, pp.1-4, 2011.

N. Nasser, N. Filho, N. , T. Neto, B. Silva et al., Giant basal cell 390 carcinoma, An Bras Dermatol, vol.87, pp.469-71, 2012.

K. Eichelmann, M. E. Garcia-melendez, O. T. Vázquez-martínez, and J. Ocampo-candiani,

, Neglected skin carcinomas: What should not be, J Eur Acad Dermatol Venereol, 2016.

A. Wainstein, T. A. De-oliveira, and D. Guelfi, Limb amputation for squamous 395 cell carcinoma of the skin: factors involved in this poor evolution, Rev Col Bras Cir, 2012.

O. Zehou, L. Valeyrie-allanore, and N. Ortonne,

, Ann Dermatol Venereol, vol.139, pp.194-202, 2012.

M. Archontaki, S. D. Stavrianos, and D. P. Korkolis, Giant Basal cell carcinoma

I. C. Naumann and S. R. Cordes, Giant basal cell carcinoma of the forehead with extensive 403 intracranial involvement, Ann Otol Rhinol Laryngol, vol.116, pp.663-669, 2007.

D. Souza, A. Clancy, and P. , Facial skin myiasis associated with advanced skin cancer

S. E. Scott, E. A. Grunfeld, J. Main, and M. Mcgurk, Patient delay in oral cancer: a qualitative 407 study of patients' experiences, Psycho-Oncology, vol.15, pp.474-85, 2006.

L. Cameron, E. A. Leventhal, and H. Leventhal, Symptom representations and affect as 409 determinants of care seeking in a community-dwelling, adult sample population, Psychology, vol.410, pp.171-180, 1993.

M. Yancovitz, C. Rizzo, and P. Julian, Patient perceptions of nonmelanoma skin 412 cancer before diagnosis, Dermatol Surg, vol.39, pp.1496-501, 2013.

A. Lomas, J. Leonardi-bee, and F. Bath-hextall, A systematic review of worldwide incidence of nonmelanoma skin cancer, Br J Dermatol, vol.166, pp.1069-80, 2012.

A. A. Jacobsen, A. S. Aldahan, and O. B. Hughes, Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies, JAMA Dermatol, vol.152, pp.816-840, 2016.

M. A. Safer, Q. J. Tharps, T. C. Jackson, and H. Levknthal, Determinants of Three Stages of Delay in Seeking Care at a Medical Clinic, Med Care, vol.17, pp.11-29, 1979.

H. De-vries, An Integrated Approach for Understanding Health Behavior; The I-Change Model as an Example, Psychol Behav Sci Int J, vol.2, pp.1-8, 2017.

J. O. Prochaska and C. C. Diclemente, Stages and processes of self-change of smoking: Toward an integrative model of change, J Consult Clin Psychol, vol.51, pp.390-395, 1983.

J. O. Prochaska, C. C. Diclemente, and J. C. Norcross, In search of how people change: Applications to addictive behaviors, Am Psychol, vol.47, pp.1102-1116, 1992.

G. Chojnacka-szaw?owska, R. Ko?cielak, and K. Karasiewicz, Delays in seeking cancer diagnosis in relation to beliefs about the curability of cancer in patients with different disease locations, Psychol Health, vol.28, pp.154-70, 2013.

W. Li, W. Lam, and J. Wong, Waiting to see the doctor: understanding appraisal and utilization components of consultation delay for new breast symptoms in Chinese women: Patient delay and breast symptoms, Psychooncology, vol.21, pp.1316-1339, 2012.

M. Alam, L. H. Goldberg, and S. Silapunt, Delayed treatment and continued growth of nonmelanoma skin cancer, J Am Acad Dermatol, vol.64, pp.839-887, 2011.

C. Renzi, S. Mastroeni, and T. J. Mannooranparampil, Timely diagnosis of cutaneous squamous cell carcinoma: the GP's role, Fam Pract, vol.28, pp.277-286, 2011.

M. Yancovitz, C. Rizzo, and P. Julian, Patient Perceptions of Nonmelanoma Skin Cancer before Diagnosis, Dermatol Surg, vol.39, pp.1496-501, 2013.

D. Kakagia, G. Trypsiannis, and M. Karanikas, Patient-Related Delay in Presentation for Cutaneous Squamous Cell Carcinoma. A Cross-Sectional Clinical Study, Oncol Res Treat, vol.36, pp.4-4, 2013.

S. L. Ristvedt and K. M. Trinkaus, Psychological factors related to delay in consultation for cancer symptoms, Psychooncology, vol.14, pp.339-50, 2005.

H. Husein-elahmed, M. Gutierrez-salmeron, R. Naranjo-sintes, A. , and J. , Factors Related to Delay in the Diagnosis of Basal Cell Carcinoma, J Cutan Med Surg, vol.17, pp.27-32, 2013.

A. Tong, P. Sainsbury, and J. Craig, Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups, Int J Qual Health Care, vol.19, pp.349-57, 2007.

J. M. Amici, M. Battistella, and M. Beylot-barry, Defining and recognising locally advanced basal cell carcinoma, Eur J Dermatol, vol.25, pp.586-94, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850494

B. Spring, Evidence-based practice in clinical psychology: What it is, why it matters

, J Clin Psychol, vol.63, pp.611-642, 2007.

P. Paillé and A. Mucchielli, Chapitre 11. L'analyse thématique, L'analyse qualitative en sciences humaines et sociales, pp.235-312, 2016.

L. K. Smith, C. Pope, and J. L. Botha, Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis, The Lancet, vol.366, pp.825-856, 2005.

J. K. Robinson, Socioeconomic Status and Attitudes of 51 Patients With Giant Basal and Squamous Cell Carcinoma and Paired Controls, Arch Dermatol, vol.131, p.428, 1995.

A. Sparsa, V. Doffoel-hantz, and H. Durox, Tumeur maligne historique : 27 cas, Ann Dermatol Vénéréologie, vol.139, pp.189-93, 2012.

G. Radiotis, N. Roberts, and Z. Czajkowska, Nonmelanoma Skin Cancer: Disease-Specific Quality-of-Life Concerns and Distress, Oncol Nurs Forum, vol.41, pp.57-65, 2014.

A. Körner, R. Garland, and Z. Czajkowska, Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about?, Eur J Oncol Nurs, vol.20, pp.150-155, 2016.

J. G. Henderson, Denial and Repression As Factors in the Delay of Patients with Cancer Presenting Themselves to the Physician, Ann N Y Acad Sci, vol.125, pp.856-64, 2006.

V. D. Kannan and P. J. Veazie, Predictors of Avoiding Medical Care and Reasons for Avoidance Behavior, Med Care, vol.52, pp.336-381, 2014.

O. Zehou, L. Valeyrie-allanore, and N. Ortonne, Tumeurs « historiques » : tumeurs négligées. Trois observations, Ann Dermatol Vénéréologie, vol.139, pp.194-202, 2012.

T. W. Reader and A. Gillespie, Patient neglect in healthcare institutions: a systematic review and conceptual model, BMC Health Serv Res, vol.13, pp.156-71, 2013.

N. A. Kasparian, J. K. Mcloone, and B. Meiser, Skin cancer-related prevention and screening behaviors: a review of the literature, J Behav Med, vol.32, pp.406-434, 2009.

S. Blackford, D. Roberts, M. S. Salek, and A. Finlay, Basal cell carcinomas cause little handicap, Qual Life Res, vol.5, pp.191-195, 1996.

A. Coulomb, Recommandations pour les carcinomes basocellulaires, Ann Dermatol Vénéréologie, vol.131, pp.661-663, 2004.

C. Dessinioti, C. Antoniou, A. Katsambas, and A. J. Stratigos, Basal Cell Carcinoma: What's New Under the Sun, Photochem Photobiol, vol.86, pp.481-91, 2010.

S. Rosso, R. Zanetti, and C. Martinez, The multicentre south European study 'Helios

, II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin, Br J Cancer, vol.73, pp.1447-54, 1996.

M. Khalesi, D. C. Whiteman, and C. Rosendahl, Basal cell carcinomas on sun-protected vs. sun-exposed body sites: a comparison of phenotypic and environmental risk factors, Photodermatol Photoimmunol Photomed, vol.31, pp.202-213, 2015.

H. W. Rogers, M. A. Weinstock, S. R. Feldman, and B. M. Coldiron, Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, JAMA Dermatol, vol.151, p.1081, 2012.

P. Bernard, A. Dupuy, and A. Sasco, Basal Cell Carcinomas and Actinic Keratoses Seen in Dermatological Practice in France: A Cross-Sectional Survey, Dermatology, vol.216, pp.194-203, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00278479

A. Coulomb and A. Nationale, Accréditation et d'Evaluation (ANAES)

, Ann Dermatol Venereol, vol.131, pp.661-756, 2004.

J. Amici, L. Dousset, and M. Battistella, Clinical factors predictive for histological aggressiveness of basal cell carcinoma: A prospective study of 2274 cases, Ann Dermatol Vénéréologie, 2019.

J. Brierley, M. K. Gospodarowicz, and C. Wittekind, TNM classification of malignant tumours, 2017.

H. W. Randle, R. K. Roenigk, and D. G. Brodland, Giant basal cell carcinoma (T3), Cancer, vol.72, pp.1624-1654, 1993.

W. J. Sahl, S. N. Snow, and N. S. Levine, Report of two cases and review of the literature, J Am Acad Dermatol, vol.30, pp.856-865, 1994.

J. M. Amici, M. Battistella, and M. Beylot-barry, Defining and recognising locally advanced basal cell carcinoma, Eur J Dermatol, vol.25, pp.586-94, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850494

A. W. Haves, P. R. Schaffer, and J. A. Carucci, The impact of inoperable advanced basal cell carcinoma: the economic, physical, and psychological burden of the disease, J Drugs Dermatol, vol.12, pp.151-153, 2013.

R. Betti, E. Inselvini, L. Moneghini, and C. Crosti, Giant basal cell carcinomas: report of four cases and considerations, J Dermatol, vol.24, pp.317-338, 1997.

G. Zoccali, R. Pajand, and P. Papa, Giant basal cell carcinoma of the skin: literature review and personal experience, J Eur Acad Dermatol Venereol, vol.26, pp.942-52, 2012.

G. Goldenberg, T. Karagiannis, and J. B. Palmer, Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study, J Am Acad Dermatol, vol.75, pp.957-966, 2016.

H. Autorité-de-santé, Erivedge 150 mg, gélule, 2013.

A. Sekulic, M. R. Migden, and A. E. Oro, Efficacy and safety of vismodegib in advanced basal-cell carcinoma, N Engl J Med, vol.366, pp.2171-2180, 2012.

N. Basset-seguin, A. Hauschild, and J. Grob, Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial, Lancet Oncol, vol.16, pp.729-765, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01989558

O. Becquart, J. Arpinon, and C. Capelle, Carcinomes basocellulaires (CBC) avancés nécessitant un traitement systémique : état des lieux du réseau CARADERM, Ann Dermatol Vénéréologie, vol.145, pp.95-101, 2018.

S. L. Shingler, J. Garside, and K. Samanta, Utilities for advanced basal cell carcinoma, J Med Econ, vol.16, pp.777-83, 2013.

M. Mccusker, N. Basset-seguin, and R. Dummer, Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease, Eur J Cancer, vol.50, pp.774-83, 2014.

M. Alam, L. H. Goldberg, and S. Silapunt, Delayed treatment and continued growth of nonmelanoma skin cancer, J Am Acad Dermatol, vol.64, pp.839-887, 2011.

R. Riefkohl, B. Wittels, and K. Mccarty, Metastatic basal cell carcinoma, Ann Plast Surg, vol.13, pp.525-533, 1984.

J. K. Robinson, J. S. Altman, and A. W. Rademaker, Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls, Arch Dermatol, vol.131, pp.428-459, 1995.

N. Basset-seguin and N. Soufir, Voie Patched/Sonic Hedgehog et carcinomes basocellulaires. médecine/sciences, vol.20, pp.899-903, 2004.

M. Wahid, A. Jawed, and R. K. Mandal, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas, Crit Rev Oncol Hematol, vol.98, pp.235-276, 2016.

A. A. Jacobsen, A. S. Aldahan, and O. B. Hughes, Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies, JAMA Dermatol, vol.152, pp.816-840, 2016.

N. Basset-séguin, A. Hauschild, and R. Kunstfeld, Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial, Eur J Cancer, vol.86, pp.334-382, 2017.

L. Mortier, N. Bertrand, and N. Basset-seguin, Vismodégib en traitement néoadjuvant du carcinome basocellulaire localement avancé : premiers résultats de l'essai de phase 2 multicentrique VISMONEO, Ann Dermatol Vénéréologie, vol.145, p.96, 2018.

E. L. Pollom, T. T. Bui, and A. Chang, Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma, JAMA Dermatol, vol.151, pp.998-1001, 2015.

J. Amici and M. Beylot-barry,

, Ann Chir Plast Esthet, vol.60, pp.321-326, 2015.

M. R. Migden, A. Guminski, and R. Gutzmer, Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial, Lancet Oncol, vol.16, pp.716-744, 2015.

J. T. Lear, M. R. Migden, and K. D. Lewis, Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study, J Eur Acad Dermatol Venereol, vol.32, pp.372-81, 2018.

D. J. Kim, J. Kim, and K. Spaunhurst, Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma, J Clin Oncol, vol.32, pp.745-51, 2014.

K. Peris, M. C. Fargnoli, and C. Garbe, Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines, Eur J Cancer Oxf Engl, vol.118, pp.10-34, 1990.

S. Ikeda, A. M. Goodman, and P. R. Cohen, Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy, Npj Genomic Med, vol.1, p.37, 2016.

G. S. Falchook, R. Leidner, and E. Stankevich, Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810, J Immunother Cancer, vol.4, 2016.

A. Chang, D. C. Tran, and J. Cannon, Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study, J Am Acad Dermatol, vol.80, pp.564-570, 2019.

T. Malmontet, L. Dousset, and E. Gerard, Synergie de la séquence immunothérapie par anti-PD1 et radiothérapie au cours d'un carcinome basocellulaire avancé, Ann Dermatol Vénéréologie, vol.147, pp.228-260, 2020.

S. D. Mathias, M. Chren, and H. H. Colwell, Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires, JAMA Dermatol, vol.150, pp.169-76, 2014.

A. W. Steenrod, E. N. Smyth, and E. N. Bush, A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma, Dermatol Ther, vol.5, pp.183-99, 2015.

M. Migden, J. Xie, and J. Wei, Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014, J Am Acad Dermatol, vol.77, pp.55-62, 2017.

J. De-nooijer, L. Lechner, and H. De-vries, A qualitative study on detecting cancer symptoms and seeking medical help; an application of Andersen's model of total patient delay, Patient Educ Couns, vol.42, pp.145-57, 2001.

M. A. Safer, Q. J. Tharps, T. C. Jackson, and H. Levknthal, Determinants of Three Stages of Delay in Seeking Care at a Medical Clinic, Med Care, vol.17, pp.11-29, 1979.

B. L. Andersen and J. T. Cacioppo, Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes, Br J Soc Psychol, vol.34, pp.33-52, 1995.

L. K. Smith, C. Pope, and J. L. Botha, Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis, The Lancet, vol.366, pp.825-856, 2005.

A. Ramirez, A. Westcombe, and C. Burgess, Factors predicting delayed presentation of symptomatic breast cancer: a systematic review, The Lancet, vol.353, pp.1127-1158, 1999.

S. E. Scott, E. A. Grunfeld, J. Main, and M. Mcgurk, Patient delay in oral cancer: a qualitative study of patients' experiences, Psychooncology, vol.15, pp.474-85, 2006.

V. Mor, S. Masterson-allen, and R. Goldberg, Pre-diagnostic symptom recognition and help seeking among cancer patients, J Community Health, vol.15, pp.253-66, 1990.

G. Montagna, A. R. Schneeberger, and L. Rossi, Can we make a portrait of women with inoperable locally advanced breast cancer?, The Breast, vol.33, pp.83-90, 2017.

M. S. Vos and J. De-haes, Denial in cancer patients, an explorative review, Psychooncology, vol.16, pp.12-25, 2007.

R. Roy, R. P. Symonds, and D. M. Kumar, The use of denial in an ethnically diverse British cancer population: a cross-sectional study, Br J Cancer, vol.92, pp.1393-1400, 2005.

R. Goldbeck, Denial in physical illness, J Psychosom Res, vol.43, pp.575-93, 1997.

E. J. Kunkel, C. M. Woods, C. Rodgers, and R. E. Myers, Consultations for 'maladaptive denial of illness' in patients with cancer: psychiatric disorders that result in noncompliance, Psychooncology, vol.6, pp.139-188, 1997.

M. A. Richard, J. J. Grob, and M. F. Avril, Delays in diagnosis and melanoma prognosis (I): the role of patients, Int J Cancer, vol.89, pp.271-280, 2000.

R. Betti, R. Vergani, and E. Tolomio, Factors of delay in the diagnosis of melanoma

, Eur J Dermatol, vol.13, pp.183-191, 2003.

W. El-charnoubi, J. B. Svendsen, U. B. Tange, and N. Kroman, Women with inoperable or locally advanced breast cancer -what characterizes them? A retrospective review of 157 cases, Acta Oncol, vol.51, pp.1081-1086, 2012.

K. L. Braun, N. Mokuau, and G. H. Hunt, Supports and obstacles to cancer survival for Hawaii's native people, Cancer Pract, vol.10, pp.192-200, 2002.

S. M. Underwood, D. Hoskins, and T. Cummins, Obstacles to cancer care: focus on the economically disadvantaged, Oncol Nurs Forum, vol.21, pp.47-52, 1994.

J. Littlewood and E. Elias, Risky shifts or shifting risk: African and African-Caribbean women's narratives on delay in seeking help for breast cancer, Risk Decis Policy, vol.5, pp.215-239, 2000.

H. F. Mathews, D. R. Lannin, and J. P. Mitchell, Coming to terms with advanced breast cancer: black women's narratives from eastern North Carolina, Soc Sci Med, vol.38, pp.789-800, 19821994.

D. Kakagia, G. Trypsiannis, and M. Karanikas, Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study, Onkologie, vol.36, pp.738-782, 2013.

C. Renzi, S. Mastroeni, and F. Passarelli, Factors associated with large cutaneous squamous cell carcinomas, J Am Acad Dermatol, vol.63, pp.404-415, 2010.

C. Renzi, S. Mastroeni, and T. J. Mannooranparampil, Delay in diagnosis and treatment of squamous cell carcinoma of the skin, Acta Derm Venereol, vol.90, pp.595-601, 2010.

D. Douard, Tumeurs cutanées avancées et historiques, pourquoi un retard de prise en charge ? Etude épidémiologique menée en Haute-Vienne et départements limitrophes, 2019.

A. Sparsa, V. Doffoel-hantz, and H. Durox, Tumeur maligne historique : 27 cas, Ann Dermatol Vénéréologie, vol.139, pp.189-93, 2012.

M. J. Eide, M. A. Weinstock, and R. G. Dufresne, Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin), J Invest Dermatol, vol.124, pp.308-322, 2005.

M. Yancovitz, C. Rizzo, and P. Julian, Patient perceptions of nonmelanoma skin cancer before diagnosis, Dermatol Surg Off Publ Am Soc Dermatol Surg Al, vol.39, pp.1496-501, 2013.

B. Antoszewski, A. Kasielska, and M. Fija?kowska, Face Skin Neoplasms -Reasons for Delayed Treatment, Pol J Surg, vol.83, 2011.

C. Renzi, S. Mastroeni, and T. J. Mannooranparampil, Timely diagnosis of cutaneous squamous cell carcinoma: the GP's role, Fam Pract, vol.28, pp.277-286, 2011.

H. Husein-elahmed, M. Gutierrez-salmeron, R. Naranjo-sintes, A. , and J. , Factors related to delay in the diagnosis of basal cell carcinoma, J Cutan Med Surg, vol.17, pp.27-32, 2013.

S. Blackford, D. Roberts, M. S. Salek, and A. Finlay, Basal cell carcinomas cause little handicap, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.5, pp.191-195, 1996.

P. Rohleder and A. Lyons, Qualitative Research in Clinical and Health Psychology, 2014.

A. Liberati, D. G. Altman, and J. Tetzlaff, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, J Clin Epidemiol, vol.62, pp.1-34, 2009.

J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated, 2011.

N. K. Denzin and Y. S. Lincoln, The SAGE handbook of qualitative research, vol.992, 2017.

L. V. Campenhoudt, J. Marquet, and R. Quivy, Manuel de recherche en sciences sociales, vol.384, 2017.

I. Hoorens, K. Vossaert, K. Ongenae, and L. Brochez, Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening, Br J Dermatol, vol.174, pp.1258-65, 2016.

, Version 1.1 12022018 -1er feuillet (original) : à conserver à part par l'investigateur pendant 30 ans dans un lieu sûr fermant à clé -2ème feuillet : à remettre au patient après signatures

, Projet Psycho-CBC

P. Psycho and -. Cbc, Grille d'entretien Soignant SERMENT D'HIPPOCRATE

, Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses